Records for a Hodgkin lymphoma consultation in China: pathology, PET images, and treatment actually given

The difficulty with records for a Hodgkin lymphoma consultation is often their relationship to one another rather than the number of files. Dozens of report photographs may still fail to explain a drug change, suspected relapse, or radiation decision if dates, treatment stages, and original images are missing. Organize the record so that a receiving team can reconstruct what actually happened.

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

Confirming a diagnosis, reviewing stage, interpreting interim PET, deciding on radiation, and assessing transplant after relapse are different tasks. Briefly identify the most important current question and the date of the next planned treatment. Active fever, breathlessness, or another acute problem should be prominent rather than buried near the end of the attachments.
A radiation summary should identify the site, total dose, dose per fraction, fraction count, dates, and technique. For possible reirradiation or review of normal-organ exposure, the receiving team may also need the original plan and dose files. A description such as several chest sessions cannot support those decisions.[S40]
Obtain new pathology opinions, the actual plan, administration records, scan interpretation, and the next clinical contact. If the decision differs from the one before travel, preserve its reason and any unresolved question. Update the first-page summary so the home clinician can see what the visit changed.[S13]

Quick answer

Full guide

A usable package can begin with a one-page account of subtype, diagnosis date, major treatment, and the current question, followed by verifiable originals. The summary is an index, not a replacement for formal reports. Ask a hospital in China about its required formats and submission routes before arrival so that unreadable data or missing tissue does not obstruct the consultation.[S13]

State the purpose of this consultation on the first page

Confirming a diagnosis, reviewing stage, interpreting interim PET, deciding on radiation, and assessing transplant after relapse are different tasks. Briefly identify the most important current question and the date of the next planned treatment. Active fever, breathlessness, or another acute problem should be prominent rather than buried near the end of the attachments.

Include the current treating service and a route for formal clinical communication. Patients and families can list their questions, but should not turn an interpretation that has not been confirmed into a diagnosis. A report awaiting review is different from biopsy-confirmed recurrence. That distinction can affect the receiving team's priorities and what should happen next.[S2]

Provide every part of the pathology report

Keep the sampling date, site, method, specimen number, diagnosis, and comments. Immunohistochemistry, in-situ hybridization, and other additions may be issued separately and should accompany the original report. A screenshot containing only the final line can omit warnings about limited tissue, a requested opinion, or tests still pending.[S66]

Where CD30, CD15, PAX5, EBER, or other results appear in a classical Hodgkin lymphoma report, preserve the original wording rather than selecting only positive results. Not every person requires an identical test panel, and markers are interpreted with tissue morphology. The patient's task is to show what was actually examined, not to recombine the stains into a new diagnosis.[S2]

Slides, blocks, and reports are different materials

A pathology opinion may require stained slides, unstained sections, or a paraffin block according to the receiving laboratory's instructions. Confirm release or shipment with the original hospital, then check specimen numbers and quantities. Glass slides need appropriate packaging rather than being transported loosely with paper documents.[S66]

If material cannot be obtained immediately, explain the reason and ask whether an initial record review is possible. The receiving pathologist should decide whether digital pathology is adequate. Do not promise that photographs taken through a microscope can always support a formal second opinion. Keep a list of material lent out and any return requirement so that it remains available for later clinical use.

Preserve baseline and subsequent PET data

Comparison requires knowing where disease was present originally and how it changed. Retain reports and DICOM data from baseline, interim, end-of-treatment, and suspected-relapse studies, with each scan identified relative to treatment cycles. The most recent scan alone may not explain a remaining structure or a new area of uptake.[S28]

Do not select only the image that looks most alarming, and do not replace the full dataset with a compressed video. Check that a disc, download, or hospital access method opens correctly. If a link expires, confirm that the receiving service can obtain what it needs before the consultation. Discovering an expired link during the review can leave a decisive comparison unavailable.

Keep the initial stage attached to its original context

The treating doctor can summarize stage at diagnosis, B symptoms, bulky disease, and important involved sites. Preserve the timing and clinical assessment of weight loss, fever, and sweats where documented. A patient's description of advanced disease is not a substitute for the original staging record.[S1]

Do not rewrite initial stage as an earlier stage simply because masses became smaller after treatment. Record stage at diagnosis separately from present response. Likewise, identify relapse sites as a later event. This lets the new team understand which risk assessment and treatment decision belonged to which point in the history, instead of trying to reconcile apparently contradictory summaries.

Document medicines actually administered

Save each regimen's full name, generic drugs, actual dates, and doses. Record why ABVD became AVD, why BV or a PD-1 medicine was added, or why a dose was omitted. The original proposal may differ from the course delivered, so the first printed treatment plan is not enough.[S20]

For medicines with different brand names across countries, an English generic-name cross-reference can accompany the unaltered original. Preserve units accurately: milligrams, milligrams per square meter, and weight-based doses should not be merged. If a cumulative dose is unavailable, ask the original service to derive it from administration records. A family member should not have to reconstruct it from memory or the number of admissions.

Show the course of important adverse effects

Serious infections, infusion reactions, neuropathy, cardiac or pulmonary problems, and immune toxicities need dates, investigations, treatment, and recovery status. A verifiable account is more useful than a nonspecific allergy flag. Separate treatment stopped for intolerance from treatment changed for lymphoma progression.[S37][S38]

After steroids or another immunosuppressant for PD-1 toxicity, provide the current dose and planned changes, along with the last immune-treatment date. Improvement in symptoms does not mean that ongoing medication can be omitted from the summary. A clinician receiving only a favorable cancer scan might otherwise miss a complication that still requires management.

Radiation records should support assessment of exposure

A radiation summary should identify the site, total dose, dose per fraction, fraction count, dates, and technique. For possible reirradiation or review of normal-organ exposure, the receiving team may also need the original plan and dose files. A description such as several chest sessions cannot support those decisions.[S40]

Keep prechemotherapy imaging with the radiation records because modern involved-site planning refers to the original disease extent. Export requirements can differ between hospitals, so the two radiation departments may need to specify a format directly. The patient can facilitate obtaining the information without personally interpreting dose maps or target contours.

Add a transplant-specific summary when relevant

State whether transplantation was autologous or allogeneic, the conditioning, reinfusion date, major complications, infections, and recovery. Collection and storage records should come from the transplant center. An allogeneic course includes donor and immune-related information and should not be reduced to a generic stem cell treatment label.[S14]

Current preventive medicines, immunosuppression, transfusion needs, and vaccination planning should also be handed over. A person traveling during recovery needs the receiving service to know the recent review frequency and the route for contacting the transplant team. A general oncology discharge letter may not replace the specialist summary needed for this stage.[S57]

Date recent tests and retain units

Recent blood counts, liver and kidney results, and existing cardiac or lung assessments can support initial review. Whether they remain valid for the next dose is for the hospital to decide. Keep dates, units, reference ranges, and the testing institution. Copying an isolated number into a summary can create confusion when laboratories use different units.

Supply original infection and viral-screening reports where available. For antimicrobial treatment, record its purpose, start date, and planned review. Do not remove an earlier abnormal result simply because the latest value is normal. The trend may help explain an admission, a delay, or a continuing preventive medicine more clearly than the most recent result alone.[S9]

Fertility and function can change the consultation

When relevant and with the patient's agreement, record whether fertility preservation was discussed, what was stored, and the responsible service. Someone who has not decided about future parenthood can still state a wish to revisit the issue before another treatment. For a potentially gonadotoxic pathway, this should not first emerge after prescribing begins.[S10][S11]

Briefly describe current appetite, weight trend, daily activity, and working ability. Needing assistance to walk, being unable to eat normally, or markedly disrupted sleep can indicate support needs that a summary of well in general does not capture. The receiving clinician needs the person's present function as well as the tumor measurements.

Obtain the requirements of an exact trial before extra testing

A study may require particular tissue, exposure details, organ results, and scan timing. Ask its team for the requirements before arranging additional investigations. A large collection of self-ordered tests may still fail to meet protocol windows and should not be performed solely on the assumption that every trial will need them.[S51]

Retain the official study identifier, screening response, and contact, but do not describe initial eligibility review as enrollment. If another trial is ongoing, tell both clinical teams about the medicine and follow-up. The research record should match the ordinary treatment history so that an exposure relevant to eligibility or safety is not omitted inadvertently.

Translation must preserve uncertainty

Pair translated pages with their originals and retain terms such as suspected, cannot exclude, or pending. Turning a possible diagnosis into a definite one for smoother wording changes the clinical meaning. Drug names, doses, dates, and positive or negative results deserve particular checking. Mark illegible details and seek clarification from the original institution rather than guessing.

Use folders organized by date and document type so the receiving team can locate originals quickly. Identify initial, additional, and corrected versions instead of deleting earlier reports without explanation. A family-prepared summary should state who prepared it and when. It should not be mistaken for a signed medical opinion from the treating hospital.

Confirm which service received which material

Submit relevant information through the hospital's designated channels and check that the responsible department can read it. Pathology and imaging may use different routes. An international office receiving an email does not establish that the pathology laboratory received glass slides. A short shipment or submission list can show what has arrived and what is still pending.

Identification should be sufficient to match records to the patient, while unrelated personal material need not be included in broadly shared files. Follow hospital procedures for originals and keep usable copies. Billing documents can be stored separately. The clinical package should make diagnosis, delivered treatment, and the current problem easy to find without searching through payment and booking paperwork.

Update the package after the consultation in China

Obtain new pathology opinions, the actual plan, administration records, scan interpretation, and the next clinical contact. If the decision differs from the one before travel, preserve its reason and any unresolved question. Update the first-page summary so the home clinician can see what the visit changed.[S13]

The records should enable the next doctor to establish the basis of diagnosis, what was really done, how the patient responded, and what remains to be addressed. A traceable sequence answers those questions more effectively than an unordered collection of screenshots. It also gives the patient a record that remains useful when another consultation occurs months or years later.